CORC

在结果中检索

CORC

浏览/检索结果: 共35条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Discovery of pyrimidine nucleoside dual prodrugs and pyrazine nucleosides as novel anti-HCV agents 期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 卷号: 27, 期号: 5, 页码: 748-759
作者:  Guo, Shuang;  Xu, Mingshuo;  Guo, Qi;  Zhu, Fuqiang;  Jiang, Xiangrui
收藏  |  浏览/下载：39/0  |  提交时间：2020/07/01
HCV core antigen is a useful predictor during pegylated-interferon/ribavirin therapy in patients with hepatitis C virus genotype 1b 期刊论文
2019, 卷号: 98, 期号: 10
作者:  Fan, Zhijuan;  Liu, Junfeng;  Wang, Fengmei;  Liu, Jingmin;  Ding, Xian
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
Daclatasvir plus asunaprevir in treatment-naive patients with hepatitis C virus genotype 1b infection 期刊论文
WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 卷号: 24, 期号: 12
作者:  Xu, Min;  Chen, Xin-Yue;  Xie, Qing;  Li, Jun;  Hou, Jin-Lin
收藏  |  浏览/下载：20/0  |  提交时间：2019/12/05
Efficacy and safety of paritaprevir/ritonavir/ombitasvir combined with dasabuvir in non-cirrhotic Asian adult patients with newly diagnosed and treated chronic HCV genotype 1b infection: a randomized, double-blind, placebo-controlled study - China data]. 期刊论文
Chinese journal of hepatology, 2018, 卷号: 26, 页码: 359-364
作者:  Wei L;  Cheng J;  Luo J;  Li Z P;  Duan J L
收藏  |  浏览/下载：13/0  |  提交时间：2019/11/19
Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir combined with ribavirin in Asian adult patients with chronic HCV genotype 1b infection and compensated cirrhosis]. 期刊论文
Chinese journal of hepatology, 2018, 卷号: 26, 页码: 353-358
作者:  Wei L;  Wang G Q;  Sarah J;  Cheng Q;  Xie M R
收藏  |  浏览/下载：8/0  |  提交时间：2019/11/19
Daclatasvir plus asunaprevir in treatment-naive patients with hepatitis C virus genotype 1b infection 期刊论文
WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 卷号: Vol.24 No.12, 页码: 1361-1372
作者:  Wei, L;  Wang, FS;  Zhang, MX;  Jia, JD;  Yakovlev, AA
收藏  |  浏览/下载：15/0  |  提交时间：2019/02/25
Real-world treatment patterns and clinical outcomes of HCV treatment-naive patients in China: an interim analysis from the CCgenos study 期刊论文
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 卷号: 32, 期号: 1
作者:  Rao, Hui-ying;  Li, Hong;  Chen, Hong;  Shang, Jia;  Xie, Qing
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/04
Real-world treatment patterns and clinical outcomes of HCV treatment-naive patients in China: an interim analysis from the CCgenos study 期刊论文
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 卷号: 32, 期号: 1
作者:  Wang, Lei;  Rao, Hui-ying;  Li, Hong;  Chen, Hong;  Shang, Jia
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
A phase 3 evaluation of daclatasvir plus asunaprevir in treatmentnaive patients with chronic HCV genotype 1b infection 期刊论文
Hepatology International, 2017, 卷号: 11
作者:  Wei L., Wang F.-S., Zhang M., Jia J., Yakovlev A.A., Xie W., Burnevich E., Niu J., Jung Y.J., Jiang X., Xu M., Chen X., Xie Q., Li J., Hou J., Tang H., Dou X., Gandhi Y., Hu W., McPhee F., Noviello S.
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
Real‐world treatment patterns and clinical outcomes of HCV treatment‐naive patients in China: an interim analysis from the CCgenos study 期刊论文
Journal of Gastroenterology and Hepatology, 2017, 卷号: 32, 期号: 1, 页码: 244-252
作者:  Rao, Hui-ying;  Li, Hong
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/03

©版权所有 ©2017 CSpace - Powered by CSpace